Iron pills as an add-on for teen eczema
Part of Genetic & congenital, Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study tests whether adding an oral iron pill to standard eczema creams helps improve symptoms in teens with atopic dermatitis. If you have mild-to-moderate eczema and are aged 12-16, the study compares usual care with and without iron to see if it reduces skin inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 16 years old.
- You must have a doctor's diagnosis of atopic dermatitis (eczema) that is mild to moderate in severity.
- You must be using stable topical (applied to the skin) treatments and agree to keep using them during the study.
- You must not have taken iron supplements by mouth or IV in the past 3 months.
- You must not have certain blood disorders or known problems with too much iron in the body.
- A parent or guardian must give written permission, and you must agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.
This study looks at how eczema may be connected to the brain and sleep, using questionnaires and MRI scans. It may help researchers understand what drives symptoms and how treatments could be improved.
This trial tests whether taking a melatonin supplement (a hormone that helps with sleep) alongside standard eczema treatment can improve symptoms in adults with atopic dermatitis. It may help reduce itching and skin inflammation, and improve sleep quality.
This study tests a daily pill, abrocitinib, to see if it safely reduces severe eczema (atopic dermatitis) in children aged 2 to under 6 years. It may help when creams or other treatments haven't worked well enough.
This study tests whether a specific diet can help manage mild to moderate eczema. It involves eating whole foods provided by the researchers for a set period and tracking your skin health.
This study tests a new medication called VC005 to treat atopic dermatitis (eczema)—a skin condition causing itching, redness, and inflammation. Researchers want to see if VC005 can safely reduce symptoms in people aged 12 and older with mild-to-moderate cases.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.